• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内镜下膀胱输尿管反流矫正的最有力决定因素是什么?对某单一机构6年经验的多变量分析。

What are the most powerful determinants of endoscopic vesicoureteral reflux correction? Multivariate analysis of a single institution experience during 6 years.

作者信息

Lorenzo Armando J, Pippi Salle Joao L, Barroso Ubirajara, Cook Anthony, Grober Ethan, Wallis M Chad, Bägli Darius J, Khoury Antoine E

机构信息

Division of Urology, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada.

出版信息

J Urol. 2006 Oct;176(4 Pt 2):1851-5. doi: 10.1016/S0022-5347(06)00599-4.

DOI:10.1016/S0022-5347(06)00599-4
PMID:16945671
Abstract

PURPOSE

As the indications for endoscopic correction of vesicoureteral reflux continue to expand, the emergence of potential predictive variables has been noted. We used univariate and multivariate statistical analyses to find the most significant predictors of correction to improve patient selection.

MATERIALS AND METHODS

A consecutive series of patients treated at a single institution was reviewed. Between August 1998 and August 2004, 232 children endoscopically injected with polydimethylsiloxane were identified, representing 351 refluxing units. A total of 23 variables were subjected to statistical analysis to detect predictors of reflux correction after injection. All identified patients with complete data and followup evaluations were included irrespective of anatomical variations, previous interventions or comorbidities.

RESULTS

The overall success rate by patient and renal unit was 65% and 72%, respectively. In patients with a single system low grade (1-3) vesicoureteral reflux who did not previously undergo injection this success rate increased to 80%. Univariate analysis demonstrated that higher physician experience, low preoperative vesicoureteral reflux grade, absent renal scars and no previous injections were statistically significant predictors of vesicoureteral reflux correction (p <0.05). A history of febrile urinary tract infections and a duplex system did not attain significance (p = 0.069 and 0.076, respectively). On multivariate statistical evaluation only physician experience, preoperative vesicoureteral reflux grade and the number of previous injections remained significant.

CONCLUSIONS

Multivariate analysis of our data showed the most important determinants of vesicoureteral reflux correction after endoscopic injection. Prospective validation will allow us to generate nomograms to better select and counsel patients who would benefit from vesicoureteral reflux treatment.

摘要

目的

随着膀胱输尿管反流内镜矫正的适应证不断扩大,已注意到潜在预测变量的出现。我们采用单变量和多变量统计分析来找出矫正的最显著预测因素,以改善患者的选择。

材料与方法

回顾了在单一机构接受治疗的一系列连续患者。1998年8月至2004年8月期间,确定了232例接受聚二甲基硅氧烷内镜注射的儿童,代表351个反流单位。对总共23个变量进行统计分析,以检测注射后反流矫正的预测因素。所有具有完整数据和随访评估的已识别患者均被纳入,无论其解剖变异、既往干预措施或合并症如何。

结果

按患者和肾单位计算的总体成功率分别为65%和72%。在先前未接受注射的单系统低级别(1 - 3级)膀胱输尿管反流患者中,这一成功率增至80%。单变量分析表明,医生经验更丰富、术前膀胱输尿管反流级别低、无肾瘢痕以及既往未接受注射是膀胱输尿管反流矫正的统计学显著预测因素(p <0.05)。发热性尿路感染病史和重复肾系统未达到显著水平(p分别为0.069和0.076)。多变量统计评估显示,只有医生经验、术前膀胱输尿管反流级别和既往注射次数仍然显著。

结论

对我们的数据进行多变量分析显示了内镜注射后膀胱输尿管反流矫正的最重要决定因素。前瞻性验证将使我们能够生成列线图,以更好地选择和咨询将从膀胱输尿管反流治疗中受益的患者。

相似文献

1
What are the most powerful determinants of endoscopic vesicoureteral reflux correction? Multivariate analysis of a single institution experience during 6 years.内镜下膀胱输尿管反流矫正的最有力决定因素是什么?对某单一机构6年经验的多变量分析。
J Urol. 2006 Oct;176(4 Pt 2):1851-5. doi: 10.1016/S0022-5347(06)00599-4.
2
Efficacy of endoscopic subureteral polydimethylsiloxane injection for treatment of vesicoureteral reflux in children: a North American clinical report.内镜下输尿管下注射聚二甲基硅氧烷治疗儿童膀胱输尿管反流的疗效:一份北美临床报告。
J Urol. 2001 Nov;166(5):1880-6.
3
Renal scarring and urinary tract infection after successful endoscopic correction of vesicoureteral reflux.膀胱输尿管反流内镜成功矫正后的肾瘢痕形成和尿路感染
J Urol. 2009 Oct;182(4 Suppl):1703-6. doi: 10.1016/j.juro.2009.03.011. Epub 2009 Aug 18.
4
Durability of a single successful endoscopic polytetrafluoroethylene injection for primary vesicoureteral reflux: 14-year followup results.单次成功内镜下聚四氟乙烯注射治疗原发性膀胱输尿管反流的持久性:14年随访结果
J Urol. 2007 Jul;178(1):265-8; discussion 268. doi: 10.1016/j.juro.2007.03.060. Epub 2007 May 17.
5
Endoscopic treatment of vesicoureteral reflux with polydimethylsiloxane in adult women.成年女性膀胱输尿管反流的聚二甲基硅氧烷内镜治疗
Eur Urol. 2004 Jun;45(6):787-9. doi: 10.1016/j.eururo.2003.11.025.
6
Endoscopic treatment of vesicoureteral reflux in children: our experience and analysis of factors affecting success rate.儿童膀胱输尿管反流的内镜治疗:我们的经验及影响成功率的因素分析
Urol Int. 2008;81(1):41-6. doi: 10.1159/000137639. Epub 2008 Jul 16.
7
Mound calcification after endoscopic treatment of vesicoureteral reflux with autologous chondrocytes--a normal variant of mound appearance?自体软骨细胞内镜治疗膀胱输尿管反流后的丘状钙化——丘状外观的正常变异?
J Urol. 2009 Jun;181(6):2702-7; discussion 2707-8. doi: 10.1016/j.juro.2009.02.053. Epub 2009 Apr 17.
8
Endoscopic treatment of vesicoureteral reflux with polydimethylsiloxane in adults: do location and appearance of the ureteric orifice have a role in the success rates?聚二甲基硅氧烷用于成人膀胱输尿管反流的内镜治疗:输尿管口的位置和外观对成功率有影响吗?
Urol Int. 2008;80(3):279-82. doi: 10.1159/000127341. Epub 2008 May 14.
9
Endoscopic treatment of vesicoureteral reflux associated with ureterocele.输尿管囊肿相关膀胱输尿管反流的内镜治疗
J Urol. 2007 Oct;178(4 Pt 2):1594-7. doi: 10.1016/j.juro.2007.03.170. Epub 2007 Aug 16.
10
Surgical versus endoscopic correction of vesicoureteral reflux in children with neurogenic bladder dysfunction.神经源性膀胱功能障碍患儿膀胱输尿管反流的手术治疗与内镜治疗对比
J Urol. 1997 Jun;157(6):2291-4.

引用本文的文献

1
Endoscopic injection of bulking agents in pediatric vesicoureteral reflux: a narrative review of the literature.内镜下注射填充剂治疗小儿膀胱输尿管反流:文献综述。
Pediatr Surg Int. 2023 Feb 18;39(1):133. doi: 10.1007/s00383-023-05426-w.
2
Brazilian consensus on vesicoureteral reflux-recommendations for clinical practice.巴西尿路上皮反流共识——临床实践建议。
Int Braz J Urol. 2020 Jul-Aug;46(4):523-537. doi: 10.1590/S1677-5538.IBJU.2019.0401.
3
Avoiding routine postoperative voiding cystourethrogram: Predicting radiologic success for endoscopically treated vesicoureteral reflux.
避免常规术后排尿性膀胱尿道造影:预测内镜治疗膀胱输尿管反流的放射学成功率。
Can Urol Assoc J. 2019 May;13(5):E119-E124. doi: 10.5489/cuaj.5589. Epub 2018 Nov 5.
4
Endoscopic injection therapy.内镜下注射治疗。
Investig Clin Urol. 2017 Jun;58(Suppl 1):S38-S45. doi: 10.4111/icu.2017.58.S1.S38. Epub 2017 Jun 2.
5
Current medical diagnosis and management of vesicoureteral reflux in children.儿童膀胱输尿管反流的当前医学诊断与管理
Nephrourol Mon. 2013 Nov 5;6(1):e13534. doi: 10.5812/numonthly.13534. eCollection 2014 Jan.
6
Endoscopic treatment of vesicoureteral reflux in pediatric patients.小儿膀胱输尿管反流的内镜治疗
Korean J Pediatr. 2013 Apr;56(4):145-50. doi: 10.3345/kjp.2013.56.4.145. Epub 2013 Apr 22.
7
Factors that impact the outcome of endoscopic correction of vesicoureteral reflux: a multivariate analysis.影响内镜下治疗膀胱输尿管反流疗效的因素:多因素分析。
Int Urol Nephrol. 2013 Feb;45(1):1-9. doi: 10.1007/s11255-012-0327-5. Epub 2012 Nov 17.
8
The impact of vesicoureteral reflux treatment on the incidence of urinary tract infection.膀胱输尿管反流治疗对尿路感染发生率的影响。
Pediatr Nephrol. 2012 Apr;27(4):529-38. doi: 10.1007/s00467-011-1809-x. Epub 2011 Mar 6.
9
Endoscopic treatment of vesicoureteral reflux with dextranomer/hyaluronic acid in children.葡聚糖凝胶/透明质酸用于儿童膀胱输尿管反流的内镜治疗
Adv Urol. 2008;2008:513854. doi: 10.1155/2008/513854.
10
Are there predictive factors for the outcome of endoscopic treatment of grade III-V vesicoureteral reflux with dextranomer/hyaluronic acid in children?对于儿童III - V级膀胱输尿管反流采用葡聚糖omer/透明质酸进行内镜治疗的结果,是否存在预测因素?
Pediatr Surg Int. 2007 Jun;23(6):585-9. doi: 10.1007/s00383-007-1881-2. Epub 2007 Mar 14.